Cerevel Therapeutics
CERE
$41.90
Share price
-0.21%
Change (1 day)
44.13%
Change (1 year)
Categories
Revenue for Cerevel Therapeutics (CERE)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cerevel Therapeutics from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $93.93 B | N/A | 🇺🇸 USA |
 Campbell Soup CPB | $9.27 B | N/A | 🇺🇸 USA |
 Dow DOW | $44.62 B | N/A | 🇺🇸 USA |
 Dupont De Nemours DD | $12.06 B | N/A | 🇺🇸 USA |